Warning:
JavaScript is turned OFF. None of the links on this page will work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Diabetes Oral Hypoglycaemic Therapy, Prandial Glucose Regulators act with digestion of Meal, Metformin (the only Biguanides) taken after a Meal, Insulin Secretion is carried out by β Cells, Sulphonylureas can lead to Weight Gain, Protein-Bound Drugs include Warfarin, Sulphonylureas stimulate Insulin Secretion, Prandial Glucose Regulators taken 15 minutes before Meal, Sulphonylureas can lead to Hypoglycaemia, Sulphonylureas can lead to Gastrointestinal Disturbance, β Cells are still functional in Type 2 Diabetes, Endogenous Insulin is available only in Type 2 Diabetes, Metformin (the only Biguanides) contraindicated in Renal Disease, Sulphonylureas increase Insulin Sensitivity, Metformin (the only Biguanides) reduces Glucose Absorption, Thiazolidinediones (Glitazones) can lead to Headache, Thiazolidinediones (Glitazones) reduce Gluconeogenesis, Oral Hypoglycaemic Therapy can consist of Sulphonylureas, Metformin (the only Biguanides) contraindicated in CVD, Sulphonylureas increase Hepatic Metabolism of Insulin, Thiazolidinediones (Glitazones) increase Insulin Sensitivity